-1.24 | -1.78%
| Price and Volume | |
|---|---|
| Recent Price | 69.73 |
| 52 Week High | 86.43 |
| 52 Week Low | 62.04 |
| Avg. Daily Vol. (Mil) | 0.10 |
| Beta (3 year) | 0.63 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,567.87 |
| Shares Out (Mil) | 36.83 |
| Float (Mil) | 30.78 |
| Dividend Information | |
| Yield % | 1.60 |
| Annual Dividend | 1.12 |
| Payout Ratio | 36.00 |
| Financial Strength | |
| Quick Ratio | 8.60 |
| Current Ratio | 10.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 22.80 |
| Price/Sales | 8.18 |
| Price/Book | 3.98 |
| Price/Cash Flow | 20.50 |
| Per Share Data | |
| Earnings | 3.06 |
| Sales | 8.52 |
| Book Value | 17.50 |
| Cash Flow | 3.41 |
| Business Summary | |
|---|---|
| Techne Corporation manufactures and sells products for the biotechnology research and clinical diagnostics market (cytokines, assays and related products) and the clinical diagnostics market (hematology controls and calibrators). | |
| General Information | |
| 614 McKinley Place N.E.
Minneapolis, MN 55413 |
|
| www.techne-corp.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 763 | |
| CEO: Mr. Thomas E. Oland | |
| Short Interest | |
| Current Month (Mil) | 0.81 |
| Previous Month (Mil) | 0.82 |
| Short Interest Ratio (Days) | 8.20 |
| Management Effectiveness | |
| Return on Equity | 17.60 |
| Return on Assets | 16.60 |
| Return on Investments | 17.60 |
| Profitability | |
| Gross Margin | 79.30 |
| EBIT Margin | 52.40 |
| Profit Margin | 36.10 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,416.30 | 1,311.70 | 2,834.60 | 16.25 |
Oil *
103.20
|
|
DOWN
164.39 |
DOWN
20.72 |
DOWN
36.39 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.31%
|
-1.56%
|
-1.27%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet